Cardiovascular risk in comorbid patients after metabolic surgery
https://doi.org/10.51922/2616-633X.2023.7.2.2041
Abstract
Cardiovascular pathology is the leading cause of mortality in the world as well as obesity and associated metabolic disorders are one of the main risk factors for the development and progression of cardiovascular diseases. For most obese patients changing lifestyle for a long period of time seems difficult especially in case of comorbidity. Metabolic surgery is currently recognized as an effective way to treat morbid obesity, reducing the incidence and risk of serious consequences of obesity-related diseases. The aim of this article was to evaluate the effect of metabolic surgery on cardiovascular events and other associated conditions in obese patients. The article provides up-to-date information on modern surgical interventions (gastric bypass, sleeve gastrectomy, mini-gastric bypass and gastric banding). We represent data on the effectiveness of metabolic surgery in obesity, hypertension and dyslipidemia. The effect of bariatric surgery on the remission of type 2 diabetes mellitus is also discussed.
About the Authors
V. Labashova
«Belarusian State Medical University»
Belarus
Belarus
Minsk
I. Pateyuk
«Belarusian State Medical University»
Belarus
Belarus
Minsk
Y. Dydyshko
«Belarusian State Medical University»
Belarus
Belarus
Minsk
S. Stebunov
State Institution «Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology»
Belarus
Belarus
Minsk
A. Kachan
«Belarusian State Medical University»
Belarus
Belarus
Minsk
M. Yelesina
«Belarusian State Medical University»
Belarus
Belarus
Minsk
A. Zarqua
«Belarusian State Medical University»
Belarus
Belarus
Minsk
N. Shpigun
«Belarusian State Medical University»
Belarus
Belarus
Minsk
References
1. Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F. [et al.] Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ, 2020, vol. 369, pp. m1985. doi: 10.1136/bmj.m1985.
2. Cariou B., Hadjadj S., Wargny M., Pichelin M., Al-Salameh A., Allix I., Amadou C., Arnault G., Baudoux F., Bauduceau B., Borot S. [et al.] Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia, 2020, vol. 63, no. 8, pp. 1500–1515.
3. Rubino F., Cohen R.V., Mingrone G., le Roux C.W., Mechanick J.I., Arterburn D.E., Vidal J., Alberti G., Amiel S.A., Batterham R.L., Bornstein S., Chamseddine G. [et al.] Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery. Lancet Diabetes Endocrinol, 2020, vol. 8, no. 7, pp. 640–648. doi: 10.1016/S2213-8587(20)30157-1.
4. Hussain A., Mahawar K., El-Hasani S. The impact of COVID-19 pandemic on obesity and bariatric surgery. Obes Surg, 2020, vol. 30, no. 8, pp. 3222–3223. doi: 10.1007/s11695-020-04637-7.
5. Angelantonio E.D., Bhupathiraju S.N., Wormser D., Gao P., Kaptoge S., Berrington de Gonzalez A., Cairns B.J., Huxley R. [et al.] The Global BMI Mortality Collaboration (Body-mass index and all-cause mortality: individual participant-data metaanalysis of 239 prospective studies in four continents. Lancet, 2016, vol. 388, pp. 776–786. doi: 10.1016/S0140-6736(16)30175-1.
6. Ivanova A.YU., Dolgalyov I.V. Vliyanie izbytochnoj massy tela i ozhireniya na smertnost’ (po rezul’tatam 27-letnego prospektivnogo issledovaniya) [Impact of overweight and obesity on mortality (according to the results of a 27-year prospective study)]. Profilakticheskaya medicina, 2017, vol. 20, no. 3, pp. 34–39. (in Russian).
7. Aune D., Sen A., Prasad M., Norat T., Janszky I., Tonstad S., Romundstad P., Vatten L.J. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ, 2016, vol. 353, pp. i2156.
8. Sonmez A., Yumuk V., Haymana C., Demirci I., Barcin C., Kıyıcı S., Güldiken S., Örük G., Ozgen Saydam B. [et al.] Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts, 2019, vol. 12, no. 2, pp. 167–178.
9. Field A. E., Manson J. E., Laird N., Williamson D.F., Willett W.C., Colditz G.A. Weight cycling and the risk of developing type 2 diabetes among adult women in the United States. Obesity research, 2004, vol. 12, no. 2, pp. 267-274.
10. Powell-Wiley T. M., Poirier P., Burke L.E., Després J.P., Gordon-Larsen P., Lavie C.J., Lear S.A., Ndumele C.E., Neeland I.J., Sanders P., St-Onge M.P. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 2021, vol. 143, no. 21, pp. e984-e1010.
11. Currie A.C., Askari A., Newton R.C., Albon L., Hawkins W., Slater G., Pring C.M. Regional variation in unmet need for metabolic surgery in England: a retrospective, multicohort analysis. Obes Surg, 2021, vol. 31, no. 1, pp. 439–444. doi: 10.1007/s11695-020-04874-w.
12. Dixon J.B. Regional differences in the coverage and uptake of bariatric-metabolic surgery: a focus on type 2 diabetes. Surg Obes Relat Dis, 2016, vol. 12, no. 6, pp. 1171–1177. doi: 10.1016/j.soard.2015.11.027.
13. Welbourn R., Dixon J., Barth J.H., Finer N., Hughes C.A., le Roux C.W., Wass J. NICE-accredited commissioning guidance for weight assessment and management clinics: a model for a specialist multidisciplinary team approach for people with severe obesity. Obes Surg, 2016, vol. 26, no. 3, pp. 649–659. doi: 10.1007/s11695-015-2041-8.
14. Welbourn R., Hopkins J., Dixon J.B., Finer N., Hughes C., Viner R., Wass J. Commissioning guidance for weight assessment and management in adults and children with severe complex obesity. Obes Rev, 2018, vol. 19, no. 1, pp. 14–27. doi: 10.1111/obr.12601.
15. Kashchenko V.A., Ctrizheleckij V.V., Nejmark A.E. [et al.] Bariatricheskaya hirurgiya [Bariatrická chirurgia] : ucheb.-metod. posobie. SPb., 2020, 48 s. : il. (in Russian).
16. O’Brien P.E., Hindle A., Brennan L., Skinner S., Burton P., Smith A., Crosthwaite G., Brown W. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obes Surg, 2019, vol. 29, no. 1, pp. 3-14. doi: 10.1007/s11695-018-3525-0.
17. Welbourn R., Hollyman M., Kinsman R., Dixon J., Liem R., Ottosson J., Ramos A., Våge V., Al-Sabah S., Brown W., Cohen R., Walton P., Himpens J. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obes. Surg., 2019, vol. 29, no. 3, pp. 782–795.
18. Stenberg E., Cao Y., Marsk R., Sundbom M., Jernberg T., Näslund E. Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study. PLoS Medicine, 2020, vol. 17, no. 9, pp. e1003307.
19. McGlone E.R., Carey I., Veličković V., Chana P., Mahawar K., Batterham R.L., Hopkins J., Walton P., Kinsman R., Byrne J., Somers S., Kerrigan D., Menon V., Borg C., Ahmed A., Sgromo B., Cheruvu C., Bano G., Leonard C., Thom H., le Roux C.W., Reddy M., Welbourn R., Small P., Khan O.A. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses. PLoS Med, 2020, vol. 17, no. 12, pp. e1003228. doi: 10.1371/journal.pmed.1003228.
20. Fink J., Seifert G., Blüher M., Fichtner-Feigl S., Marjanovic G. Obesity Surgery. Dtsch Arztebl Int, 2022, vol. 119, no. 5, pp. 70–80. doi: 10.3238/arztebl.m2021.0359.
21. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Bulfone L., Maglianno D.J., O’Brien P.E. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care, 2009, vol. 32, no. 4, pp. 567–574. doi: 10.2337/dc08-1749. Epub 2009.
22. Currie A.C., Askari A., Fangueiro A., Mahawar K. Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes. Obes Surg, 2021, vol. 31, no. 10, pp. 4528–4541.
23. Fisher D.P., Johnson E., Haneuse S., Arterburn D., Coleman K.J., O’Connor P.J., O’Brien R., Bogart A., Theis M.K., Anau J., Schroeder E.B., Sidney S. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA, 2018, vol. 320, no. 15, pp. 1570–1582. doi: 10.1001/jama.2018.14619.
24. Sheng B., Truong K., Spitler H., Zhang L., Tong X., Chen L. The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. Obes Surg, 2017, vol. 27, no. 10, pp. 2724–2732. doi: 10.1007/s11695-017-2866-4.
25. Johnson B.L., Blackhurst D.W., Latham B.B., Cull D.L.., Bour E.S., Oliver T.L., Williams B., Taylor S.M., Scott J.D. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg, 2013, vol. 216, no. 4, pp. 545–556. doi: 10.1016/j.jamcollsurg.2012.12.019.
26. Anveden Å., Taube M., Peltonen M., Jacobson P., Andersson-Assarsson J.C., Sjöholm K., Svensson P.A. Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecologic Oncology, 2017, vol. 145, no. 2, pp. 224–229.
27. Keating C.L., Dixon J.B., Moodie M.L., Peeters A., Bulfone L., Maglianno D.J., O’Brien P.E. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes care, 2009, vol. 32, no. 4, pp. 567–574.
28. Eisenberg D., Shikora S.A., Aarts E., Aminian A., Angrisani L., Cohen R.V., de Luca M., Faria S.L. [et al.] 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis, 2022, vol. 18, no. 12, pp. 1345–1356.
29. Berkovskaya M.A., Kushkhanashkhova D.A., Sych Yu.P., Fadeev V.V. Sostoyanie fosforno-kal’cievogo obmena u pacientov posle bariatricheskih operacij i rol’ vospolneniya deficita vitamina D v profilaktike i lechenii posleoperacionnyh kostno-metabolicheskih narushenij [Characteristics of calcium and phosphorous metabolism in patients after bariatric surgery and the role of vitamin d supplementation in the prevention and treatment of postoperative bone and mineral disorders]. Obesity and metabolism, 2020, vol. 17, no. 1, pp. 73–81. (in Russian).
30. Kim E.I., Ershova E.V., Mazurina N.V., Komshilova K.A. Postbariatricheskie gipoglikemii: vzglyad endokrinologa [A view at postbariatric hypoglycemia by endocrinologist]. Obesity and metabolism, 2021, vol. 18, no. 4, pp. 471–483. (in Russian).
31. Mulita F., Lampropoulos C., Kehagias D., Verras G.I., Tchabashvili L., Kaplanis C., Liolis E., Iliopoulos F. [et al.] Long-term nutritional deficiencies following sleeve gastrectomy: a 6-year single-centre retrospective study. Prz. Menopauzalny, 2021, vol. 20, no. 4, pp. 170–176.
Review
For citations:
Labashova V., Pateyuk I., Dydyshko Y., Stebunov S., Kachan A., Yelesina M., Zarqua A., Shpigun N. Cardiovascular risk in comorbid patients after metabolic surgery. Emergency Cardiology and Cardiovascular Risks journal. 2023;7(2):2041-2049. (In Russ.) https://doi.org/10.51922/2616-633X.2023.7.2.2041
Views:
9
Email this article 